man |
TDLo |
intravenous |
3536units/kg/ (3536units/kg) |
|
Southern Medical Journal. Vol. 80, Pg. 1450, 1987. |
man |
TDLo |
subcutaneous |
1857units/kg/ (1857units/kg) |
CARDIAC: OTHER CHANGES |
Southern Medical Journal. Vol. 80, Pg. 1450, 1987. |
mouse |
LD50 |
intraperitoneal |
1900mg/kg (1900mg/kg) |
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: MUSCLE WEAKNESS |
Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 60, Pg. 507, 1964. |
mouse |
LD50 |
intravenous |
500mg/kg (500mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) |
Arzneimittel-Forschung. Drug Research. Vol. 36, Pg. 1366, 1986. |
mouse |
LD50 |
subcutaneous |
500mg/kg (500mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: MUSCLE WEAKNESS |
Arzneimittel-Forschung. Drug Research. Vol. 36, Pg. 1366, 1986. |
rat |
LD50 |
oral |
1950mg/kg (1950mg/kg) |
|
German Offenlegungsschrift Patent Document. Vol. #2636091, |
rat |
LDLo |
intraperitoneal |
420mg/kg (420mg/kg) |
|
Toxicology and Applied Pharmacology. Vol. 1, Pg. 156, 1959. |
women |
TDLo |
subcutaneous |
30uL/kg/5D-I (0.03mL/kg) |
SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" |
British Journal of Haematology. Vol. 82, Pg. 620, 1992. |
women |
TDLo |
subcutaneous |
48mg/kg/20D-I (48mg/kg) |
BLOOD: HEMORRHAGE
SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" |
Australian and New Zealand Journal of Medicine. Vol. 28, Pg. 59, 1998. |
women |
TDLo |
subcutaneous |
1000units/kg/ (1000units/kg) |
|
Southern Medical Journal. Vol. 80, Pg. 1450, 1987. |